Ovid Therapeutics Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Exchange Agreements (1 contract)
- Guarantee Agreements (1)
- Investor Rights Agreements (1)
- Stock Agreements (3)
- Underwriting Agreements (6)
- Underwriting Agreement related to the Offering, dated August 25, 2020, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on August 26, 2020)
- Underwriting Agreement related to the Preferred Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on October 8, 2019)
- Underwriting Agreement related to the Common Offering, dated October 4, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on October 8, 2019)
- Exchange Agreement among Ovid Therapeutics Inc. and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value Trading Fund OS, L.P., dated... (Filed With SEC on September 19, 2019)
- Form of Series A Preferred Stock Certificate (Filed With SEC on February 21, 2019)
- Underwriting Agreement related to the Preferred Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on February 21, 2019)
- Underwriting Agreement related to the Common Offering, dated February 20, 2019, among Ovid Therapeutics Inc. and Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on February 21, 2019)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (Filed With SEC on April 25, 2017)
- OVID THERAPEUTICS INC. 2017 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:[ ] APPROVED BY THE STOCKHOLDERS:[ ] (Filed With SEC on April 18, 2017)
- Ovid Therapeutics Inc. [] Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on April 18, 2017)
- SERIES B-1 PREFERRED STOCK PURCHASE AGREEMENT TABLE OF CONTENTS (Filed With SEC on April 10, 2017)
- SECOND AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on April 10, 2017)
